However, differences in trial design and patient backgrounds, such as baseline A1C and concurrent use of metformin, make direct comparisons challenging
Use with caution in heart, kidney, or blood pressure conditions
The corollary , if youre not seeing meaningful loss after 34 months at a therapeutic dose, semaglutide may not be the right drug for you , is worth discussing with your prescriber early
This mirrors the natural pattern of GH secretion, which occurs in 4-6 pulses per daypredominantly during deep sleep
However, the panel, chaired by Stefanie Schle and comprising first examiner Josep Gimenez Miralles and second examiner Heidi van den Bulcke, came to a different conclusion and upheld EP 111
No evidence of hormonal, hepatic, or systemic adverse effects has been observed in available data